News & Updates
Showing Neurology articles
Showing

DAPT with cilostazol reduces stroke recurrence without raising bleeding risk
Dual antiplatelet therapy (DAPT) using cilostazol appears to be more beneficial than single antiplatelet therapy, with the results of a study suggesting that DAPT helps lower the incidence of ischemic stroke recurrence without increasing the risk of severe or life-threatening bleeding.
DAPT with cilostazol reduces stroke recurrence without raising bleeding risk
07 Feb 2023
Modified Atkins diet may be better than keto for childhood drug-resistant epilepsy
Dietary modifications offer short-term benefits in children with drug-resistant epilepsy, but modified Atkins diet appears more tolerable and more likely to reduce the frequency of seizures than ketogenic diet, as shown in a study.
Modified Atkins diet may be better than keto for childhood drug-resistant epilepsy
05 Feb 2023
Antipsychotic prescriptions for dementia soared during COVID-19 pandemic
The overall rate of antipsychotic drug prescriptions to patients with dementia increased markedly during the initial months of the COVID-19 pandemic, and did not return to prepandemic levels when the acute phase was over, a multinational network cohort study has shown.
Antipsychotic prescriptions for dementia soared during COVID-19 pandemic
02 Feb 2023
Physical activity helps prevent dementia, cognitive impairment in women
Walking daily and performing moderate-to-vigorous physical activity can help lower the risk of mild cognitive impairment (MCI) or dementia in ageing women, as shown in a study.
Physical activity helps prevent dementia, cognitive impairment in women
30 Jan 2023
Diabetes linked to elevated serum neurofilament light chain levels
A recent study has found an association between diabetes mellitus and higher serum neurofilament light chain (sNfL), biomarkers of neuroaxonal injury in multiple neurological diseases, in a US population.
Diabetes linked to elevated serum neurofilament light chain levels
28 Jan 2023
Add-on cannabidiol induces sustained seizure reduction in treatment-resistant epilepsy
Patients with treatment-resistant epilepsy appear to benefit from add-on cannabidiol, which a recent study has shown to help reduce seizure frequency for up to 192 weeks.



